AAPS 2026 PharmSci 360
Advancing your molecule with speed and agility through digital innovation, technical expertise, and the power of one global network
October 25–28, 2026 | New Orleans, LA | Booth #1637
About AAPS 2026 PharmSci 360
AAPS PharmSci 360 is an annual event organized by the American Association of Pharmaceutical Scientists (AAPS). The event convenes thousands of pharmaceutical science professionals from around the world and across the drug development process to discuss the latest advancements in pharmaceutical science and technology.
This year’s event will take place October 25–28, 2026, at the Ernest N. Morial Convention Center in New Orleans, LA. Key topics of conversation will include preclinical and translational sciences, bioanalytics, manufacturing and analytical characterization, and formulation and delivery. We look forward to seeing you in New Orleans soon.
Event details
Date: October 25–28, 2026
Format: In-person
Location: New Orleans, LA
Booth number: #1637
Event website: PharmSci 360 - American Association of Pharmaceutical Scientists
Why Thermo Fisher Scientific?
Connect with Thermo Fisher Scientific’s team of experts at AAPS 2026 PharmSci 360 to explore how we can help biotech and pharma companies make smarter, more strategic decisions earlier in the drug development journey and solve complex formulation challenges quickly so they can scale with confidence.
Our integrated CDMO services span API and drug product development, formulation, analytical testing, clinical and commercial manufacturing, packaging, supply chain, and regulatory support for small and large molecules. These capabilities are supported by an expansive network of state-of-the-art facilities, experienced scientific teams, and a strong regulatory track record.
Attend our sponsored session
- Date: Tuesday, October 27
- Time: 9:00–10:00 a.m. ET
- Location: Stage 3
Expanding the formulation toolbox: Scalable solutions for solubility and bioavailability enhancement
This talk explores challenges with poorly soluble compounds and the technologies used to help improve bioavailability. Our approach leverages an internally developed in-silico platform to aid prediction of technologies and formulation strategies based on the API’s structure and physicochemical properties, facilitating material-sparing early development and screening to assess performance and stability. Various enabling technologies for amorphous dispersion (spray drying, hot-melt extrusion, KinetiSol™, etc.) will be discussed, highlighting advantages, limitations, scale-up, and manufacturability, as well as case studies demonstrating scalable solutions from feasibility through commercialization.
Speakers:
- Ramesh Muttavarapu, Global SME, OSD, Thermo Fisher Scientific
- Andrew West, Staff Scientist, Thermo Fisher Scientific
Meet us at AAPS 2026 PharmSci 360
We look forward to seeing you in New Orleans. Pre-book a meeting with our team below.
Stay connected to new discoveries, innovations, and expert scientific opinions.
Follow us on social media for the latest up-to-date event happenings.
We look forward to seeing you soon